UK-based Pharmaceutical Company (NDA Protected)
A pharmaceutical company based in the United Kingdom was developing a regulated injectable product and required a reliable, compliant, and scalable injection device solution for clinical and commercial use. Due to strict regulatory requirements and confidentiality obligations, the project was conducted under a Non-Disclosure Agreement (NDA).
High-quality injection device compliant with EU & UK regulatory standards Stable and consistent performance for pharmaceutical applications Capability to support medium-to-large volume orders Reliable delivery schedule and professional technical support Long-term partnership potential for future scale-up
We provided a customized injection device solution tailored to the client’s formulation and application requirements. Our team supported the project from
Key highlights of our solution included: Pharmaceutical-grade materials and controlled manufacturing processes Consistent dose delivery and user-friendly design Strict quality inspection and batch traceability Flexible production capacity to meet scaling needs
Successfully delivered 50,000+ units in the initial cooperation phase Met all agreed quality and delivery requirements Passed the client’s internal evaluation and validation process Established a foundation for long-term cooperation and repeat orders
This collaboration enabled the client to move forward confidently with their injectable product development while ensuring supply chain stability and regulatory confidence. Our ability to support NDA projects and deliver at scale strengthened our position as a trusted injection device partner for pharmaceutical companies in Europe.
This case demonstrates our capability to support UK and EU pharmaceutical clients, handle NDA-protected projects, and deliver tens of thousands of units with consistent quality and reliability.